These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reduction of mononuclear cytokine production in hemodialysis patients treated with steam-sterilized low-flux polysulphone membranes. Aucella F; Vigilante M; Grandone E; Colaizzo D; Margaglione M; Modoni S; Orlandini G; Stallone C Int J Artif Organs; 1998 Apr; 21(4):210-5. PubMed ID: 9649062 [TBL] [Abstract][Full Text] [Related]
24. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924 [TBL] [Abstract][Full Text] [Related]
25. A review of the concept of biocompatibility. Schulman G Kidney Int Suppl; 1993 Jun; 41():S209-12. PubMed ID: 8320923 [TBL] [Abstract][Full Text] [Related]
26. Cytokines and biocompatibility. Dinarello CA Blood Purif; 1990; 8(4):208-13. PubMed ID: 1964790 [TBL] [Abstract][Full Text] [Related]
27. Effect of continuous ambulatory peritoneal dialysis on anemia in uremic patients. Marcovici O; Boner G; Rosenfeld JB Isr J Med Sci; 1983 Jul; 19(7):604-7. PubMed ID: 6885343 [TBL] [Abstract][Full Text] [Related]
28. Biocompatibility of artificial organs: an overview. Henderson LW; Chenoweth D Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344 [TBL] [Abstract][Full Text] [Related]
29. Adsorption dialysis: from physical principles to clinical applications. Aucella F; Gesuete A; Vigilante M; Prencipe M Blood Purif; 2013; 35 Suppl 2():42-7. PubMed ID: 23676835 [TBL] [Abstract][Full Text] [Related]
30. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders. Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286 [TBL] [Abstract][Full Text] [Related]
31. Long-term complications of dialysis: infection. Khan IH; Catto GR Kidney Int Suppl; 1993 Jun; 41():S143-8. PubMed ID: 8320909 [TBL] [Abstract][Full Text] [Related]
32. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A Nephron; 1998; 78(4):395-402. PubMed ID: 9578065 [TBL] [Abstract][Full Text] [Related]
33. The neutrophil function of uremic patients treated by hemodialysis or CAPD. Huttunen K; Lampainen E; Silvennoinen-Kassinen S; Tiilikainen A Scand J Urol Nephrol; 1984; 18(2):167-72. PubMed ID: 6463600 [TBL] [Abstract][Full Text] [Related]